|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0008976,
umls-concept:C0020823,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0043227,
umls-concept:C0079083,
umls-concept:C0205179,
umls-concept:C0205390,
umls-concept:C0239307,
umls-concept:C0684249,
umls-concept:C1518904,
umls-concept:C1563350,
umls-concept:C1563351
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1998-5-12
|
|
pubmed:abstractText |
A phase III randomized trial in patients with advanced non-small-cell lung cancer (NSCLC) was performed to determine if the addition of ifosfamide to moderate-dose cisplatin and carboplatin improved response rate (primary end point) and survival.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:AlexopoulosC GCG,
pubmed-author:BerchierM CMC,
pubmed-author:BureauGG,
pubmed-author:EfremidisAA,
pubmed-author:GinerVV,
pubmed-author:KlasterskyJJ,
pubmed-author:LafitteJ JJJ,
pubmed-author:LecomteJJ,
pubmed-author:MommenPP,
pubmed-author:NinaneVV,
pubmed-author:PaesmansMM,
pubmed-author:SculierJ PJP,
pubmed-author:ThiriauxJJ,
pubmed-author:ZachariaeMM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1388-96
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9552042-Adult,
pubmed-meshheading:9552042-Aged,
pubmed-meshheading:9552042-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9552042-Carboplatin,
pubmed-meshheading:9552042-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:9552042-Cisplatin,
pubmed-meshheading:9552042-Female,
pubmed-meshheading:9552042-Humans,
pubmed-meshheading:9552042-Ifosfamide,
pubmed-meshheading:9552042-Lung Neoplasms,
pubmed-meshheading:9552042-Male,
pubmed-meshheading:9552042-Middle Aged,
pubmed-meshheading:9552042-Prognosis,
pubmed-meshheading:9552042-Survival Rate
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
|
|
pubmed:affiliation |
Institut Jules Bordet, Bruxelles, Belgium. 101473.1044@compuserve.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase III
|
